Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001999371-24-007813
Filing Date
2024-06-26
Accepted
2024-06-26 16:52:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS tnxp-424b5_062624.htm 424B5 294650
2 GRAPHIC tonix_img01.jpg GRAPHIC 13407
3 GRAPHIC tonix_img02.jpg GRAPHIC 16658
4 GRAPHIC tonix_img03.jpg GRAPHIC 7861
  Complete submission text file 0001999371-24-007813.txt   348403
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266982 | Film No.: 241074300
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)